Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Ingredion Inc (INGR)

Ingredion Inc (INGR)
127.51 -0.59 (-0.46%) 04/10/25 [NYSE]
N/A x N/A 140.80 x 100
Realtime by (Cboe BZX)
N/A x N/A 140.80 x 100
Realtime 127.51 unch (unch) 16:01 ET
Quote Overview for Thu, Apr 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
124.14
Day High
128.49
Open 126.80
Previous Close 128.10 128.10
Volume 452,100 452,100
Avg Vol 675,000 675,000
Stochastic %K 30.85% 30.85%
Weighted Alpha +8.68 +8.68
5-Day Change -8.90 (-6.52%) -8.90 (-6.52%)
52-Week Range 109.51 - 155.44 109.51 - 155.44
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,222,226
  • Shares Outstanding, K 64,186
  • Annual Sales, $ 7,430 M
  • Annual Income, $ 647,000 K
  • EBIT $ 883 M
  • EBITDA $ 1,097 M
  • 60-Month Beta 0.72
  • Price/Sales 1.06
  • Price/Cash Flow 8.69
  • Price/Book 2.10

Options Overview Details

View History
  • Implied Volatility 38.34% ( -5.33%)
  • Historical Volatility 28.30%
  • IV Percentile 99%
  • IV Rank 83.82%
  • IV High 43.67% on 04/08/25
  • IV Low 10.70% on 05/10/24
  • Put/Call Vol Ratio 0.06
  • Today's Volume 33
  • Volume Avg (30-Day) 19
  • Put/Call OI Ratio 0.81
  • Today's Open Interest 1,459
  • Open Int (30-Day) 1,452

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 2.49
  • Number of Estimates 1
  • High Estimate 2.49
  • Low Estimate 2.49
  • Prior Year 2.08
  • Growth Rate Est. (year over year) +19.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
120.51 +5.81%
on 04/09/25
Period Open: 136.79
137.80 -7.47%
on 04/03/25
-9.28 (-6.78%)
since 03/10/25
3-Month
120.51 +5.81%
on 04/09/25
Period Open: 130.81
139.81 -8.80%
on 03/10/25
-3.30 (-2.52%)
since 01/10/25
52-Week
109.51 +16.44%
on 04/16/24
Period Open: 112.88
155.44 -17.97%
on 11/06/24
+14.63 (+12.96%)
since 04/10/24

Most Recent Stories

More News
Ingredion Incorporated Declares Quarterly Dividend Of $0.80 Per Share

INGR : 127.51 (-0.46%)
Ingredion Named to World's Most Ethical Companies List for 11th Year

INGR : 127.51 (-0.46%)
Ingredion Invests $50 Million in Cedar Rapids, Iowa Facility to Expand Specialty Industrial Starch Capacity for Packaging and Papermaking Industries

INGR : 127.51 (-0.46%)
Ingredion Invests $100 Million in Indianapolis Plant to Improve Efficiency and Enable Future Texture Solutions Growth

INGR : 127.51 (-0.46%)
Ingredion: Q4 Earnings Snapshot

Ingredion: Q4 Earnings Snapshot

INGR : 127.51 (-0.46%)
Ingredion Incorporated Reports Strong 2024 Fourth Quarter and Full-Year Results

INGR : 127.51 (-0.46%)
Ingredion Named to 2025 FORTUNE World's Most Admired Companies List for 15th Time

INGR : 127.51 (-0.46%)
Ingredion to Release 2024 Fourth Quarter and Year-end Financial Results on Feb. 4, 2025

INGR : 127.51 (-0.46%)
How Should You Play Post Holdings Stock at a P/S Multiple of 0.8X?

Post Holdings, Inc. POST is trading at an attractive valuation, considering its price-to-sales (P/S) multiple, which is lower than the Zacks Food – Miscellaneous industry and the broader Consumer Staples...

FRPT : 78.17 (-5.68%)
INGR : 127.51 (-0.46%)
POST : 115.58 (-0.40%)
UNFI : 23.73 (-5.76%)
Will Lamb Weston Stock Bounce Back in 2025 After Recent Slump?

Lamb Weston Holdings, Inc. LW has experienced an 18.5% decline in its share price over the past six months, raising concerns among investors. This decline is steeper than the 2.3% decline in its industry...

FRPT : 78.17 (-5.68%)
INGR : 127.51 (-0.46%)
UNFI : 23.73 (-5.76%)
LW : 53.91 (-2.44%)
Insider Sale: President and CEO of $SLDB (SLDB) Sells 11,114 Shares

Alexander Cumbo, the President and CEO of $SLDB ($SLDB), sold 11,114 shares of the company on 12-03-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 22.4%...

SLDB : 2.67 (-2.55%)
Insider Sale: Chief Technology Officer of $SLDB (SLDB) Sells 2,777 Shares

Paul Herzich, the Chief Technology Officer of $SLDB ($SLDB), sold 2,777 shares of the company on 12-03-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 18.6%...

SLDB : 2.67 (-2.55%)
Solid Biosciences Announces Collaboration with Mayo Clinic to Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene Therapies

SLDB : 2.67 (-2.55%)
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SLDB : 2.67 (-2.55%)
Solid Biosciences to Participate at Upcoming Investor Conferences

SLDB : 2.67 (-2.55%)
Solid Biosciences to Present at the Jefferies London Healthcare Conference

SLDB : 2.67 (-2.55%)
Solid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Updates

SLDB : 2.67 (-2.55%)
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SLDB : 2.67 (-2.55%)
Solid Biosciences to Participate at the Truist Securities BioPharma Symposium

SLDB : 2.67 (-2.55%)
Are Gene Therapy Stocks The Market's Next Big Winners?

Biotechs Sarepta and BioMarin are among companies advancing cutting-edge gene therapies, although those treatments can come with a $2 million or more price.

SRPT : 50.31 (-9.60%)
BMRN : 56.32 (-5.23%)
BIIB : 113.38 (-5.90%)
CRSP : 34.26 (-1.81%)
EDIT : 1.1100 (-3.48%)
NTLA : 6.77 (-4.38%)
NVS : 103.40 (-0.43%)
ORTX : 16.70 (+0.30%)
REGN : 546.39 (-5.26%)
SLDB : 2.67 (-2.55%)
BLUE : 4.67 (-3.71%)
Insider Sale: President and CEO of $SLDB (SLDB) Sells 11,114 Shares

Alexander Cumbo, the President and CEO of $SLDB ($SLDB), sold 11,114 shares of the company on 12-03-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 22.4%...

SLDB : 2.67 (-2.55%)
Insider Sale: Chief Technology Officer of $SLDB (SLDB) Sells 2,777 Shares

Paul Herzich, the Chief Technology Officer of $SLDB ($SLDB), sold 2,777 shares of the company on 12-03-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 18.6%...

SLDB : 2.67 (-2.55%)
Solid Biosciences Announces Collaboration with Mayo Clinic to Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene Therapies

SLDB : 2.67 (-2.55%)
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SLDB : 2.67 (-2.55%)
Solid Biosciences to Participate at Upcoming Investor Conferences

SLDB : 2.67 (-2.55%)
Solid Biosciences to Present at the Jefferies London Healthcare Conference

SLDB : 2.67 (-2.55%)
Solid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Updates

SLDB : 2.67 (-2.55%)
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SLDB : 2.67 (-2.55%)
Solid Biosciences to Participate at the Truist Securities BioPharma Symposium

SLDB : 2.67 (-2.55%)
Are Gene Therapy Stocks The Market's Next Big Winners?

Biotechs Sarepta and BioMarin are among companies advancing cutting-edge gene therapies, although those treatments can come with a $2 million or more price.

SRPT : 50.31 (-9.60%)
BMRN : 56.32 (-5.23%)
BIIB : 113.38 (-5.90%)
CRSP : 34.26 (-1.81%)
EDIT : 1.1100 (-3.48%)
NTLA : 6.77 (-4.38%)
NVS : 103.40 (-0.43%)
ORTX : 16.70 (+0.30%)
REGN : 546.39 (-5.26%)
SLDB : 2.67 (-2.55%)
BLUE : 4.67 (-3.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Ingredion Incorporated is an ingredients solutions provider specializing in nature-based sweeteners, starches and nutrition ingredients. The Company serves diverse sectors in food, beverage, brewing, pharmaceuticals and other industries. Its sweetener products include dextrose, glucose, polyols, HFCS...

See More

Key Turning Points

3rd Resistance Point 133.64
2nd Resistance Point 131.06
1st Resistance Point 129.29
Last Price 127.51
1st Support Level 124.94
2nd Support Level 122.36
3rd Support Level 120.59

See More

52-Week High 155.44
Fibonacci 61.8% 137.89
Fibonacci 50% 132.48
Last Price 127.51
Fibonacci 38.2% 127.06
52-Week Low 109.51

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.